Jianhong Fan
Fan Jianhong Senior Partner
Capital Markets
Corporate and M&A
Cross-Border Investment and Trade
Dispute Resolution
Detailed introduction
As a core partner of Dentons Shanghai Capital Markets Practice, Fan Jianhong brings 15+ years of experience in complex securities transactions since joining upon obtaining her LL.M. from Xiamen University in 2007. Currently serves on the internal review committees of both Zhongtai Securities and Dentons.
Public Offerings & Listings
• Led 10+ A-share IPOs across Shanghai/Shenzhen exchanges (e.g., Anzheng Fashion 603839)
• Structured Hong Kong red-chip listings (e.g., Kaiyi Holdings 02011.HK)
• Pioneered BSE listings (e.g., Suzhou Xujie Tech among first selective tier listings)
M&A Transactions
• Aviation Industry Corp: Acquired top-3 chemical tanker operator
• Bunge (Fortune 500): PRC feed processing plant acquisition
• Yurun Food: Cross-border restructuring of HK2.2bnassets•WeirSemiconductor:US2.2bnassets•WeirSemiconductor:US100m+ overseas asset acquisition
Debt Capital Markets
• Shanghai Municipal: RMB 10bn FTZ bond (city's inaugural issue)
• Pacific Insurance: RMB 5bn tier-2 capital bonds
• Danyang Investment: Pandemic-response MTN (market innovation)
Notable Clients:
• State-owned: AVIC, Shanghai Municipal Group
• Financial: Guotai Junan, SPDB
• Multinationals: Chanel, Bloomberg, Leggett & Platt
• Healthcare: Sanford Health, Origin Bioscience
Biotech/Life Sciences
• Structured 5+ financing rounds for Origin Bioscience (IDG, Matrix Partners)
• Advised 3 medical device IPOs (Linhua Medical, XinGaoyi)
"Red-chip Dismantling: Ten Critical Questions" (China Business Law Journal)
• Xiamen University - LL.M. in International Law
• Chongqing University - LL.B. in Economic Law
2011-Present: Partner, Dentons
2007-2011: Associate, Dentons
• PRC Bar License
• Shanghai Bar Association Member